Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer

• Egile Nagusiak: Gupta Digant (Egilea), Lammersfeld Carolyn A (Egilea), Vashi Pankaj G (Egilea), Braun Donald P (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2010-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>We investigated the prognostic impact of changes in serum CA125 levels during the first 3 months of therapy in ovarian cancer.</p> <p>Methods</p> <p>A case series of 170 ovarian cancer patients treated at Canc...